Interventional device developer Abbott Vascular has begun the international launch of its Xience V everolimus-eluting coronary stent system, according to the Redwood City, CA-based company.
The device is expected to be offered in European countries immediately, Abbot said.
By AuntMinnie.com staff writers
October 3, 2006
Related Reading
Abbott nets CE Mark for Emboshield Pro, September 13, 2006
Abbott completes Guidant vascular unit purchase, April 21, 2006
Abbott debuts catheter for chronic occlusions, February 27, 2006
Abbott amends Boston Scientific agreement, January 17, 2006
Abbott gets approval for vessel closure device, December 23, 2005
Copyright © 2006 AuntMinnie.com